In fact, a recent clinical study using targeted next-generation sequencing (NGS) reports that sons born to PCOS women present lower methylation of CpG sites in three regions of the AMH promoter compared with sons of non-PCOS mothers [133]. The gene discussed is AMH; the disease is polycystic ovary syndrome.